An analysis of the German National Cohort (NAKO) examined the prevalence, incidence, functional limitations and mortality among study participants with medically confirmed or probable Parkinson’s disease over a period of five years. The analysis revealed that those affected were, on average, older, more likely to be male and had a higher burden of comorbidities. Compared with people without Parkinson’s, the risk of death was around four times higher among those with Parkinson’s.
A research team led by the University of Münster analysed data from around 204,000 participants in the German National Cohort (NAKO). The researchers determined the proportion of people who had Parkinson’s disease at the time of the first NAKO examination between 2014 and 2019 (prevalence), as well as the number of new cases during the subsequent period from 2019 to 2024 (incidence).
As it was not possible to carry out a specialist neurological examination in a cohort as large as NAKO, three methodological approaches were used to determine the prevalence of Parkinson’s syndrome: self-reported information from participants, medically billed diagnoses, and a classification algorithm based on self-reported information and details of medication. Based on prescribed medication, in addition to information on the duration of the condition, an assessment was made as to whether a person definitely or probably had Parkinson’s disease. The analysis took into account active ingredients typically used to treat Parkinson’s disease.
Using this algorithm, the prevalence was 0.13 per cent. This means that, of the total of 204,273 people examined, 272 had been diagnosed with Parkinson’s disease according to this criterion. By contrast, the prevalence based on medical billing diagnoses was approximately 2 to 2.5 times higher. The incidence, based on self-reported data, was 0.13 per cent over an average observation period of 4.8 years. People with Parkinson’s had an approximately four times higher risk of death compared with those without Parkinson’s.
The analysis also showed that people with medically confirmed or probable Parkinson’s disease were, on average, older, and that men were affected more frequently than women. Cardiovascular comorbidities, such as high blood pressure, were more common in people with Parkinson’s disease, as was depression. “The latter is consistent with the recognised role of depressive symptoms as a non-motor symptom and a possible early manifestation of Parkinson’s disease. Other chronic conditions and multimorbidity were also observed more frequently in the group of people with Parkinson’s, indicating a higher overall burden of disease,” explains Prof. Dr Klaus Berger, Head of the Institute of Epidemiology and Social Medicine at the University of Münster. “Our data also confirm the impact of Parkinson’s disease on mortality and activities of daily living.”
About Parkinson’s disease
Parkinson’s disease is a progressive neurodegenerative disorder. The loss of dopamine-producing nerve cells leads to symptoms such as slowed movement, muscle stiffness, tremors at rest and balance problems. In Germany, around 295,000 people were living with a diagnosed case of Parkinson’s disease in 2022. The prevalence increases significantly with age and stands at around 1.4 per cent among people aged 65 and over. [1]